SRRK

Scholar Rock Holding
SRRK

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$3.08B
EV
$2.71B
Shares Outstanding
99.19M
Beta
0.58

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$50.50
P/E 2025E
-
P/Revenue 2025E
116.35x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Scholar Rock Holding Corporation

gainify
SRRK

Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegroma...

Sector

Healthcare

Industry

Biotechnology

CEO

Backstrom, Jay

Employees

128

IPO Date

2018-05-25

Headquarters

301 Binney Street, 3rd Floor, Cambridge, Massachusetts, 02142, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved